Kreisl TN - Search Results

1

Ischemic stroke in patients with primary brain tumors.

Kreisl TN, Toothaker T, Karimi S, DeAngelis LM. Kreisl TN, et al. Neurology. 2008 Jun 10;70(24):2314-20. doi: 10.1212/01.wnl.0000314648.82924.6f. Neurology. 2008. PMID: 18541885

2

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.

Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE. Kreisl TN, et al. Leuk Lymphoma. 2008 Sep;49(9):1710-6. doi: 10.1080/10428190802238560. Leuk Lymphoma. 2008. PMID: 18661394

3

Neurologic complications of antitumor antibody therapies.

Kreisl TN. Kreisl TN. Curr Neurol Neurosci Rep. 2008 May;8(3):259-63. doi: 10.1007/s11910-008-0039-5. Curr Neurol Neurosci Rep. 2008. PMID: 18541121 Review.

4

Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy.

Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Fraum TJ, et al. Among authors: kreisl tn. J Neurooncol. 2011 Nov;105(2):281-9. doi: 10.1007/s11060-011-0579-4. Epub 2011 Apr 27. J Neurooncol. 2011. PMID: 21603965 Free PMC article.

5

Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas: A Retrospective Observational Study.

Barbaro M, Blinderman CD, Iwamoto FM, Kreisl TN, Welch MR, Odia Y, Donovan LE, Joanta-Gomez AE, Evans KA, Lassman AB. Barbaro M, et al. Among authors: kreisl tn. Neurology. 2022 Jan 18;98(3):e260-e266. doi: 10.1212/WNL.0000000000013057. Epub 2021 Nov 18. Neurology. 2022. PMID: 34795049 Free PMC article.

6

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA. Lehky TJ, et al. Among authors: kreisl tn. Neurology. 2011 Jan 18;76(3):236-41. doi: 10.1212/WNL.0b013e3182074a69. Neurology. 2011. PMID: 21242491 Free PMC article.

7

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.

Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA. Iwamoto FM, et al. Among authors: kreisl tn. Cancer. 2010 Apr 1;116(7):1776-82. doi: 10.1002/cncr.24957. Cancer. 2010. PMID: 20143438 Free PMC article. Clinical Trial.

8

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma.

Kreisl TN, Zhang W, Odia Y, Shih JH, Butman JA, Hammoud D, Iwamoto FM, Sul J, Fine HA. Kreisl TN, et al. Neuro Oncol. 2011 Oct;13(10):1143-50. doi: 10.1093/neuonc/nor091. Epub 2011 Aug 24. Neuro Oncol. 2011. PMID: 21865400 Free PMC article. Clinical Trial.

9

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.

Odia Y, Kreisl TN, Aregawi D, Innis EK, Fine HA. Odia Y, et al. Among authors: kreisl tn. J Neurooncol. 2015 Oct;125(1):191-5. doi: 10.1007/s11060-015-1894-y. Epub 2015 Aug 19. J Neurooncol. 2015. PMID: 26285768 Clinical Trial.

10

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

Odia Y, Iwamoto FM, Moustakas A, Fraum TJ, Salgado CA, Li A, Kreisl TN, Sul J, Butman JA, Fine HA. Odia Y, et al. Among authors: kreisl tn. J Neurooncol. 2016 Mar;127(1):127-35. doi: 10.1007/s11060-015-2020-x. Epub 2015 Dec 7. J Neurooncol. 2016. PMID: 26643807 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters